Rishu Takimoto, Takashi Kamigaki, Hisao Ito, Masashi Saito, Ken Takizawa, Kenzo Soejima, Hiroyuki Yasuda, Keiko Ohgino, Hideki Terai, Katsuro Tomita, Miyabi Miura, Eishiro Mizukoshi, Tomoharu Miyashita, Yasunari Nakamoto, Katsuhiro Hayashi, Shinji Miwa, Masaaki Kitahara, Akihiko Takeuchi, Hiroaki Kimura, Takafumi Mochizuki, Hiroki Sugie, Ken-Ichiro Seino, Tomonori Yamada, Syuhei Takeuchi, Kaori Makita, Keiko Naitoh, Kosei Yasumoto, Yoichiro Yoshida, Hiroyuki Inoue, Katsuhiro Kotake, Kihachi Ohshima, Shin-Ei Noda, Masahiko Okamoto, Yuya Yoshimoto, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto
BACKGROUND AIMS: With the aim of strengthening the scientific evidence of immune-cell therapy for cancer and further examining its safety, in October 2015, our hospital jointly established the Cancer Immune-Cell Therapy Evaluation Group (CITEG) with 39 medical facilities nationwide. METHODS: Medical information, such as patients' background characteristics, clinical efficacy and therapeutic cell types obtained from each facility, has been accumulated, analyzed and evaluated by CITEG...
July 22, 2023: Cytotherapy